Literature DB >> 32891881

Thelazia rhodesi in a dairy farm in Romania and successful treatment using eprinomectin.

Georgiana Deak1, Angela Monica Ionică2, Nicuşor-Valentin Oros3, Călin Mircea Gherman3, Andrei Daniel Mihalca3.   

Abstract

Bovine thelaziosis can be caused by Thelazia rhodesi Desmarest 1828, Thelazia gulosa Railliet & Henry 1910 and Thelazia skrjabini Erschow 1928 which are known to be transmitted by species of Muscidae. Therapeutic measures in cattle include mechanical removal of the adult parasites, followed by irrigation of the conjunctival sac with different solutions such as levamisole (1%) or administration of ivermectin (0.2 mg/kg SC), doramectin (0.2 mg/kg SC or pour-on) both with high efficacy, however, the use of such macrocyclic lactones can be problematic in lactating cattle. Nematodes harboured in the eyes of some cattle from Romania were morphologically identified as Thelazia rhodesi and the PCR analysis confirmed the diagnosis with a 98.0% nucleotide similarity for ITS1 sequence, with other sequences available in GenBank. The present paper reports the presence of T. rhodesi in cattle from a dairy farm in Romania and the recovery after treatment with eprinomectin. To the best of our knowledge this is the first report on the efficacy of eprinomectin against Thelazia spp. and the first molecular confirmation of T. rhodesi in Romania.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Eprinomectin; Romania; Thelazia rhodesi; Treatment

Mesh:

Substances:

Year:  2020        PMID: 32891881     DOI: 10.1016/j.parint.2020.102183

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  1 in total

1.  Efficacy of fipronil/(S)-methoprene/eprinomectin/praziquantel (Broadline®) against Thelazia callipaeda in naturally infected cats.

Authors:  Stefania Zanet; Simone Morelli; Angela Di Cesare; Stefano Bò; Donato Traversa; Wilfried Lebon; Frederic Beugnet; Giulia Simonato; Ezio Ferroglio
Journal:  Parasit Vectors       Date:  2021-09-15       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.